Our preliminary data in clinically resistant GBM specimens also suggested association of expression between SOD2 and Bmi-1, a protein related to stem cell factors and drug resistance [38] (N = 10, r = 0.82, P < 0.01, Additional file 7: Figure S7). Here, BMI1 is linked to glioblastoma.